Equities Research Analysts’ upgrades for Friday, February 9th:

Archer Daniels Midland (NYSE:ADM) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Archer Daniels came out with solid fourth-quarter 2017 earnings, wherein the bottom line beat estimates and increased year over year, backed by its strategic initiatives. Notably, the company remains on track with the accomplishments regarding operational excellence and readiness program, and is likely to continue with further 1ADM rollouts in 2018. Also, it plans to achieve $200 million in run-rate savings by the end of 2018. However, Archer Daniels has lagged the industry in a year, primarily due to its dismal sales surprise history for more than three years now. Unfortunately, the drab trend lingered in the fourth quarter, wherein the top line was marred by softness across most units. Nonetheless, Oilseeds posted improved sales, and is likely to keep up its favorable trend in future. Also, management remains encouraged to deliver growth in 2018 through cost-savings efforts, enhanced capabilities, product innovations and global strength.”

American International Group (NYSE:AIG) was upgraded by analysts at Bank of America Corp from a neutral rating to a buy rating.

Air Products & Chemicals (NYSE:APD) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Yamana Gold (NYSE:AUY) (TSE:YRI) was upgraded by analysts at Macquarie from a neutral rating to an outperform rating.

BB&T (NYSE:BBT) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

BorgWarner (NYSE:BWA) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating.

Comerica (NYSE:CMA) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. BMO Capital Markets currently has $111.00 price target on the stock.

Cummins (NYSE:CMI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $193.00 target price on the stock. According to Zacks, “Cummins earnings and revenues topped the Zacks Consensus Estimate in the fourth-quarter. Both the metrics were higher than the year-ago figures. Moreover, the company provided a bullish outlook for fiscal 2018. It expects high profitability on the basis of higher sales and cost reduction initiatives in the current year. Cummins has also achieved its target of returning 50% of full-year operating cash flow to its shareholders in the form of share repurchases and dividends to boost their confidence in the company. It plans to achieve the same target in 2018 as well. Additionally, Cummins’ recent acquisitions in the electrified power segment will enable it to achieve the aim of being a leader in electrified power.”

California Resources (NYSE:CRC) was upgraded by analysts at Societe Generale from a hold rating to a buy rating.

Control4 (NASDAQ:CTRL) was upgraded by analysts at Maxim Group from a hold rating to a buy rating. They currently have $36.00 price target on the stock, up from their previous price target of $33.00.

Chevron (NYSE:CVX) was upgraded by analysts at Royal Bank of Canada from an underperform rating to a sector perform rating.

Endocyte (NASDAQ:ECYT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “In October 2017, Endocyte accelerated its path to commercialization as it acquired the rights to PSMA-617, being evaluated for the treatment of prostate cancer. The candidate represents a more than $1 billion market opportunity and its development is now the main priority of the company. Currently, the company plans to focus on its most promising programs – lutetium PSMA-617 radioligand therapy and prostate cancer, and CAR T-cell small-molecule drug conjugates (SMDC) adaptor platform. In the last one year, shares of the company have outperformed the industry. However, Endocyte has very few candidates in its pipeline with all of them in the early or mid-stages of development. With no approved product in its portfolio at the moment, Endocyte has to depend heavily on its partners for top-line growth. Endocyte’s products will face intense competition in the market from both large pharma companies and small and mid-sized companies.”

eGain (NASDAQ:EGAN) was upgraded by analysts at Benchmark Co. from a hold rating to a buy rating.

Emerson Electric (NYSE:EMR) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Essex Property Trust (NYSE:ESS) was upgraded by analysts at Mizuho from an underperform rating to a neutral rating. They noted that the move was a valuation call. The analysts noted that the move was a valuation call.

FireEye (NASDAQ:FEYE) was upgraded by analysts at UBS Group AG from a neutral rating to a positive rating.

First Financial Bancorp (NASDAQ:FFBC) was upgraded by analysts at FIG Partners from a market perform rating to an outperform rating.

First Horizon National (NYSE:FHN) was upgraded by analysts at Barclays PLC from an equal weight rating to an overweight rating.

Fidelity National Information Servcs (NYSE:FIS) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $108.00 price target on the stock. According to Zacks, “Shares of Fidelity National Information Services have underperformed the industry, over the past six months. Yet, the company displays an impressive earnings surprise history. It surpassed the Zacks Consensus Estimate for earnings in each of the trailing four quarters. Fourth-quarter 2017 results reflected lower expenses and easing margin pressure but revenues decreased. The company remains well positioned for growth backed by its attractive core business with a recurring revenue model, digitization, diversified product portfolio, benefits from strategic acquisitions, as well as several ongoing strategic initiatives. It anticipates 2018 adjusted earnings per share in the band of $5.10-$5.30, reflecting an increase of about 15-20% year over year. Though, the company remains exposed to significant competition from new entrants, its involvement in steady capital deployment activities encourages us.”

Fiserv (NASDAQ:FISV) was upgraded by analysts at SunTrust Banks, Inc. from a hold rating to a buy rating.

First Mid-Illinois Bancshares (NASDAQ:FMBH) was upgraded by analysts at DA Davidson from a neutral rating to a buy rating.

HB Fuller (NYSE:FUL) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Green Plains Partners (NASDAQ:GPP) was upgraded by analysts at Stifel Nicolaus from a hold rating to a buy rating. They currently have $20.00 target price on the stock.

Imperva (NASDAQ:IMPV) was upgraded by analysts at Piper Jaffray Companies from a neutral rating to an overweight rating.

iRobot (NASDAQ:IRBT) was upgraded by analysts at JPMorgan Chase & Co. from an underweight rating to a neutral rating.

Mettler-Toledo International (NYSE:MTD) was upgraded by analysts at Citigroup Inc from a neutral rating to a buy rating.

National Australia Bank (OTCMKTS:NABZY) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Oshkosh (NYSE:OSK) was upgraded by analysts at Evercore ISI to an outperform rating.

Paycom Software (NYSE:PAYC) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $97.00 target price on the stock. According to Zacks, “Provider of cloud-based HCM software as a service solution, Paycom has outperformed the broader market over the last one year. The company reported outstanding fourth-quarter 2017 results and provided an encouraging first-quarter and full year 2018 revenue guidance. Revenue growth seems to be steady and was positively impacted by higher recurring revenues and higher traction in cloud-based offerings. Better-than-expected demand for advanced human capital management and payroll software solutions during the reported quarter were the other positives. Going ahead, Paycom might witness long-term growth by successfully cross-selling newer products to the existing client base, which will boost revenues. Nevertheless, competition from companies likes Paylocity Holding Corporation, Intuit Inc. and Paychex, Inc. remains a headwind.”

PennantPark Investment (NASDAQ:PNNT) was upgraded by analysts at Ladenburg Thalmann Financial Services from a neutral rating to a buy rating.

Regeneron Pharmaceuticals (NASDAQ:REGN) was upgraded by analysts at Robert W. Baird from a neutral rating to an outperform rating.

Regal Entertainment Group (NYSE:RGC) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Regal Entertainment Group is a leading motion picture exhibitor operating the largest theatre circuit in the United States. The Company’s nationwide theatre circuit is comprised of Regal Cinemas Corporation, United Artists Theatre Company and Edwards Theatres, Inc. “

Suburban Propane Partners (NYSE:SPH) was upgraded by analysts at UBS Group AG from a market perform rating to an outperform rating.

Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by analysts at JPMorgan Chase & Co. from a neutral rating to an overweight rating.

Suncor Energy (NYSE:SU) (TSE:SU) was upgraded by analysts at TD Securities from a hold rating to a buy rating.

Southwestern Energy (NYSE:SWN) was upgraded by analysts at B. Riley from a neutral rating to a buy rating. They currently have $5.85 target price on the stock, up from their previous target price of $5.00.

TCF Financial (NYSE:TCF) was upgraded by analysts at BMO Capital Markets from a market perform rating to an outperform rating. They currently have $26.00 price target on the stock.

Telefonica (NYSE:TEF) was upgraded by analysts at Jefferies Group LLC from an underperform rating to a hold rating.

Teva Pharmaceutical Industries (NYSE:TEVA) was upgraded by analysts at Royal Bank of Canada from an underperform rating to a sector perform rating. They currently have $13.00 price target on the stock, down from their previous price target of $18.00.

T-Mobile US (NASDAQ:TMUS) was upgraded by analysts at UBS Group AG from an outperform rating to a strong-buy rating.

Domtar (NYSE:UFS) (TSE:UFS) was upgraded by analysts at Royal Bank of Canada from a sector perform rating to an outperform rating. Royal Bank of Canada currently has $50.00 price target on the stock.

United Technologies (NYSE:UTX) was upgraded by analysts at Argus from a hold rating to a buy rating.

Viacom (NASDAQ:VIAB) was upgraded by analysts at Royal Bank of Canada from an underperform rating to a sector perform rating.

Receive News & Ratings for Archer Daniels Midland Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Archer Daniels Midland Co and related companies with MarketBeat.com's FREE daily email newsletter.